Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 862

    1.

    The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.

    Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, Merrill JT, Sammaritano L, Lockshin M, Alarcón GS, Manzi S, Belmont HM, Askanase AD, Sigler L, Dooley MA, Von Feldt J, McCune WJ, Friedman A, Wachs J, Cronin M, Hearth-Holmes M, Tan M, Licciardi F.

    Ann Intern Med. 2005 Jun 21;142(12 Pt 1):953-62.PMID: 15968009 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Combined oral contraceptives in women with systemic lupus erythematosus.

    Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, McCune WJ, Hearth-Holmes M, Dooley MA, Von Feldt J, Friedman A, Tan M, Davis J, Cronin M, Diamond B, Mackay M, Sigler L, Fillius M, Rupel A, Licciardi F, Buyon JP; OC-SELENA Trial.

    N Engl J Med. 2005 Dec 15;353(24):2550-8.PMID: 16354891 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.

    Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ, Ouyang P, Thompson P, Tardif JC, Higginson L, Bittner V, Steffes M, Gordon DJ, Proschan M, Younes N, Verter JI.

    JAMA. 2002 Nov 20;288(19):2432-40.PMID: 12435256 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Menopause hormonal therapy in women with systemic lupus erythematosus.

    Sánchez-Guerrero J, González-Pérez M, Durand-Carbajal M, Lara-Reyes P, Jiménez-Santana L, Romero-Díaz J, Cravioto MD.

    Arthritis Rheum. 2007 Sep;56(9):3070-9.PMID: 17763408 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Estrogen plus progestin and risk of venous thrombosis.

    Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, Sidney S, Rosendaal FR; Women's Health Initiative Investigators.

    JAMA. 2004 Oct 6;292(13):1573-80.PMID: 15467059 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

    Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J; WHIMS Investigators.

    JAMA. 2003 May 28;289(20):2651-62.PMID: 12771112 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Summaries for patients. Hormone replacement therapy does not increase severe lupus flares.

    [No authors listed]

    Ann Intern Med. 2005 Jun 21;142(12 Pt 1):I22. No abstract available. PMID: 15968006 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Hormone replacement therapy in postmenopausal women with systemic lupus erythematosus.

    Buyon JP.

    J Am Med Womens Assoc. 1998 Winter;53(1):13-7. Review.PMID: 9458619 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

    Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D; WHIMS Investigators.

    JAMA. 2003 May 28;289(20):2663-72.PMID: 12771113 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Hormone replacement therapy in systemic lupus erythematosus.

    Kreidstein S, Urowitz MB, Gladman DD, Gough J.

    J Rheumatol. 1997 Nov;24(11):2149-52.PMID: 9375875 [PubMed - indexed for MEDLINE]Related articles

    12.

    Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.

    Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, Vittinghoff E, Hulley S.

    Ann Intern Med. 2000 May 2;132(9):689-96.PMID: 10787361 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus.

    Mok CC, Lau CS, Ho CT, Lee KW, Mok MY, Wong RW.

    Scand J Rheumatol. 1998;27(5):342-6.PMID: 9808396 [PubMed - indexed for MEDLINE]Related articles

    14.

    The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.

    Tseng CE, Buyon JP, Kim M, Belmont HM, Mackay M, Diamond B, Marder G, Rosenthal P, Haines K, Ilie V, Abramson SB.

    Arthritis Rheum. 2006 Nov;54(11):3623-32.PMID: 17075807 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.

    Vieira CS, Pereira FV, de Sá MF, Paulo LJ, Martins WP, Ferriani RA.

    Maturitas. 2009 Mar 20;62(3):311-6. Epub 2009 Feb 3.PMID: 19193505 [PubMed - indexed for MEDLINE]Related articles

    16.

    Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease.

    Hochman J, Urowitz MB, Ibañez D, Gladman DD.

    Lupus. 2009 Apr;18(4):313-7.PMID: 19276299 [PubMed - indexed for MEDLINE]Related articles

    17.

    Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.

    Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, Barrett-Connor E; Heart and Estrogen/progestin Replacement Study.

    Ann Intern Med. 2003 Jan 7;138(1):1-9.PMID: 12513038 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

    Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S; Women's Health Initiative Steering Committee.

    JAMA. 2004 Apr 14;291(14):1701-12.PMID: 15082697 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

    Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH; Women's Health Initiative Memory Study.

    JAMA. 2004 Jun 23;291(24):2947-58.PMID: 15213206 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data